Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: A retrospective cohort study

Breast Cancer Research

Volumn 13, Issue 3, 2011, Pages

  Patnaik, Jennifer L ^a   Byers, Tim ^a   DiGuiseppi, Carolyn ^a   Dabelea, Dana ^a   Denberg, Thomas D ^b  

^a Department of Civil and Environmental Engineering at Colorado State University and the Department of Environmental and Occupational Health at the Colorado School of Public Health   (United States)

^b HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

AGE; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER STAGING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; RISK REDUCTION; BREAST TUMOR; CANCER REGISTRY; MORTALITY;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEER PROGRAM;

EID: 84860389031     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2901     Document Type: Article

References (32)

1. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK, . (editors) SEER Cancer Statistics Review, 1975-2006 2009, Bethesda, MD: National Cancer Institute, (editors).
2. Jatoi I, Chen BE, Anderson WF, Rosenber PS. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 2007, 25:1683-1690. 10.1200/JCO.2006.09.2106, 17404367.
3. McKenzie F, Jeffreys M. Do lifestyle or social factors explain ethnic/racial inequalities in breast cancer survival?. Epidemiol Rev 2009, 31:52-66. 10.1093/epirev/mxp007, 19675112.
4. Dunwald LK, Rossing MA, Li CI. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 2007, 9:R6. 10.1186/bcr1639, 1851385, 17239243.
5. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: an overview. Med Care 2002, 40(8 Suppl):IV26-IV35.
6. Yancik R, Wesley MN, Ries LAG, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001, 285:885-892. 10.1001/jama.285.7.885, 11180731.
7. Louwman WJ, Janssen-Heijnen ML, Houterman S, Voogd AC, van der Sangen MJC, Nieuwenhuijzen GAP, Coeborgh JWW. Less extensive treatment and inferior prognosis for breast cancer patients with comorbidity: a population-based study. Eur J Cancer 2005, 41:779-785. 10.1016/j.ejca.2004.12.025, 15763655.
8. National Cancer Institute Surveillance Epidemiology and End Results. National Cancer Institute., http://seer.cancer.gov/
9. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002, 40(8 Suppl):IV3-IV18.
10. National Cancer Institute SEER-Medicare Linked Database. National Cancer Institute., http://healthservices.cancer.gov/seermedicare/
11. US Public Health Service International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) 92-1260. Hyattsville, MD: National Center for Health Statistics, US Public Health Service., http://www.cdc.gov/nchs/icd/icd9cm.htm
12. American Medical Association Physicians Current Procedural Terminology: CPT 95 1994, Chicago: American Medical Association, 5, American Medical Association.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
14. Charlson ME, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994, 47:1245-1251. 10.1016/0895-4356(94)90129-5, 7722560.
15. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-619. 10.1016/0895-4356(92)90133-8, 1607900.
16. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000, 53:1258-1267. 10.1016/S0895-4356(00)00256-0, 11146273.
17. United Nations Handbook of Vital Statistics Systems and Methods: Legal, Organization and Technical Aspects 1991, I. New York: United Nations, Glossary, Series F, No. 35, United Nations.
18. R package NestedCohort. , http://cran.r-project.org/web/packages/NestedCohort/index.html
19. Centers for Disease Control and Prevention, The Merck Company Foundation. The State of Aging and Health in America Report 2007, Whitehouse Station, NJ: The Merck Company Foundation., http://apps.nccd.cdc.gov/SAHA/Default/Default.aspx
20. Centers for Disease Control and Prevention National Vital Statistics System Mortality Data. 2010, Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention., http://www.cdc.gov/nchs/deaths.htm
21. Azim HA, de Azambuja E, Colozza M, Bines J, Piccart MJ. Long-term toxic effects of adjuvant chemotherapy in breast cancer. Ann Oncol
22. Fish EB, Chapman JAW, Link MA. Competing causes of death for primary breast cancer. Ann Surg Oncol 1998, 5:368-375. 10.1007/BF02303502, 9641460.
23. Chapman JW, Meng D, Shepherd L, Parulekar W, Ingle JN, Muss HB, Palmer M, Yu C, Goss PE. Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J Natl Cancer Inst 2008, 100:252-260. 10.1093/jnci/djn014, 2745611, 18270335.
24. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994, 120:104-110.
25. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 2005, 294:1765-1772. 10.1001/jama.294.14.1765, 16219879.
26. World Health Organization International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10) 1994, 2. Geneva: World Health Organization, World Health Organization.
27. Hoel DG, Ron E, Carter R, Mabuchi K. Influence of death certificate errors on cancer mortality trends. J Natl Cancer Inst 1993, 85:1063-1068. 10.1093/jnci/85.13.1063, 8515493.
28. Lenfant C, Friedman L, Thorn T. Fifty years of death certificates: the Framingham Heart Study. Ann Intern Med 1998, 129:1066-1067.
29. Kirsner RS, Ma F, Fleming L, Federman DG, Trapido E, Duncan R, Wilkinson JD. The effect of Medicare health care delivery systems on survival for patients with breast and colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006, 15:769-773. 10.1158/1055-9965.EPI-05-0838, 16614122.
30. Beck SL, Towsley GL, Caserta MS, Lindau K, Dudley WN. Symptom experiences and quality of life of rural and urban older adult cancer survivors. Cancer Nurs 2009, 32:359-369. 10.1097/NCC.0b013e3181a52533, 19661799.
31. Ganz PA. Survivorship: adult cancer survivors. Prim Care 2009, 36:721-741.
32. Giordano SH, Hortobagyi GN. Time to remove the subspecialty blinders: breast cancer does not exist in isolation. J Natl Cancer Inst 2008, 100:230-231. 10.1093/jnci/djn015, 18270334.